Charles Schwab’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-94,996
| Closed | -$211K | – | 3573 |
|
|
2021
Q1 | $211K | Buy |
94,996
+10,059
| +12% | +$22.3K | ﹤0.01% | 3310 |
|
|
2020
Q4 | $211K | Hold |
84,937
| – | – | ﹤0.01% | 3252 |
|
|
2020
Q3 | $209K | Hold |
84,937
| – | – | ﹤0.01% | 3163 |
|
|
2020
Q2 | $302K | Buy |
+84,937
| New | +$302K | ﹤0.01% | 3044 |
|
|
2019
Q2 | – | Sell |
-60,400
| Closed | -$119K | – | 3282 |
|
|
2019
Q1 | $119K | Hold |
60,400
| – | – | ﹤0.01% | 3081 |
|
|
2018
Q4 | $80K | Hold |
60,400
| – | – | ﹤0.01% | 3107 |
|
|
2018
Q3 | $149K | Buy |
60,400
+10,000
| +20% | +$24.7K | ﹤0.01% | 3100 |
|
|
2018
Q2 | $170K | Hold |
50,400
| – | – | ﹤0.01% | 3079 |
|
|
2018
Q1 | $214K | Hold |
50,400
| – | – | ﹤0.01% | 2971 |
|
|
2017
Q4 | $167K | Hold |
50,400
| – | – | ﹤0.01% | 3007 |
|
|
2017
Q3 | $193K | Hold |
50,400
| – | – | ﹤0.01% | 3018 |
|
|
2017
Q2 | $222K | Buy |
+50,400
| New | +$222K | ﹤0.01% | 2994 |
|